Variation in the Region of the Angiotensin-Converting Enzyme Gene Influences Interindividual Differences in Blood Pressure Levels in Young White Males

DOI Web Site 被引用文献9件
  • Myriam Fornage
    From the Human Genetics Center (M.F., E.B.) and the Institute of Molecular Medicine (E.B.), University of Texas at Houston Health Science Center; the Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston (C.I.A.); the Department of Human Genetics, University of Michigan, Ann Arbor (S.K., C.F.S.); and the Division of Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minn (S.T.T.).
  • Christopher I. Amos
    From the Human Genetics Center (M.F., E.B.) and the Institute of Molecular Medicine (E.B.), University of Texas at Houston Health Science Center; the Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston (C.I.A.); the Department of Human Genetics, University of Michigan, Ann Arbor (S.K., C.F.S.); and the Division of Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minn (S.T.T.).
  • Sharon Kardia
    From the Human Genetics Center (M.F., E.B.) and the Institute of Molecular Medicine (E.B.), University of Texas at Houston Health Science Center; the Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston (C.I.A.); the Department of Human Genetics, University of Michigan, Ann Arbor (S.K., C.F.S.); and the Division of Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minn (S.T.T.).
  • Charles F. Sing
    From the Human Genetics Center (M.F., E.B.) and the Institute of Molecular Medicine (E.B.), University of Texas at Houston Health Science Center; the Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston (C.I.A.); the Department of Human Genetics, University of Michigan, Ann Arbor (S.K., C.F.S.); and the Division of Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minn (S.T.T.).
  • Stephen T. Turner
    From the Human Genetics Center (M.F., E.B.) and the Institute of Molecular Medicine (E.B.), University of Texas at Houston Health Science Center; the Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston (C.I.A.); the Department of Human Genetics, University of Michigan, Ann Arbor (S.K., C.F.S.); and the Division of Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minn (S.T.T.).
  • Eric Boerwinkle
    From the Human Genetics Center (M.F., E.B.) and the Institute of Molecular Medicine (E.B.), University of Texas at Houston Health Science Center; the Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston (C.I.A.); the Department of Human Genetics, University of Michigan, Ann Arbor (S.K., C.F.S.); and the Division of Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minn (S.T.T.).

抄録

<jats:p> <jats:italic>Background</jats:italic> —The renin-angiotensin system regulates blood pressure through its effects on vascular tone, renal hemodynamics, and renal sodium and fluid balance. </jats:p> <jats:p> <jats:italic>Methods and Results</jats:italic> —Using data from a large population-based sample of 1488 siblings having a mean age of 14.8 years and belonging to the youngest generation of 583 randomly ascertained three-generation pedigrees from Rochester, Minn, we carried out variance components–based linkage analyses to evaluate the contribution of variation in four renin-angiotensin system gene regions (angiotensinogen, renin, angiotensin I–converting enzyme, and angiotensin II receptor type 1) to interindividual variation in systolic, diastolic, and mean arterial pressure. We rejected the null hypothesis that allelic variation in the region of the angiotensin-converting enzyme ( <jats:italic>ACE</jats:italic> ) gene does not contribute to interindividual blood pressure variability. After conditioning on measured covariates, variation in this region accounted for 0%, 13% ( <jats:italic>P</jats:italic> =0.04), and 16% ( <jats:italic>P</jats:italic> =0.04) of the interindividual variance in systolic, diastolic, and mean arterial pressures, respectively. These estimates were even greater in a subset of subjects with a positive family history of hypertension (0%, 29% [ <jats:italic>P</jats:italic> =0.005], and 32% [ <jats:italic>P</jats:italic> <0.005], respectively). In sex-specific analyses, genetic variation in the region of the <jats:italic>ACE</jats:italic> gene significantly influenced interindividual blood pressure variation in males (37% for SBP [ <jats:italic>P</jats:italic> =0.03], 38% for DBP [ <jats:italic>P</jats:italic> =0.04], and 53% for MAP [ <jats:italic>P</jats:italic> <0.005]) but not in females. </jats:p> <jats:p> <jats:italic>Conclusions</jats:italic> —Although it is possible that variation in a gene near the <jats:italic>ACE</jats:italic> gene may explain the observed results, knowledge about the physiological involvement of ACE in blood pressure regulation supports the proposition that the <jats:italic>ACE</jats:italic> gene itself influences blood pressure variability in a sex-specific manner. </jats:p>

収録刊行物

  • Circulation

    Circulation 97 (18), 1773-1779, 1998-05-12

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (9)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ